annual cash & cash equivalents:
$127.67M-$7.89M(-5.82%)Summary
- As of today (May 20, 2025), CORT annual cash & cash equivalents is $127.67 million, with the most recent change of -$7.89 million (-5.82%) on December 31, 2024.
- During the last 3 years, CORT annual cash & cash equivalents has risen by +$50.05 million (+64.48%).
- CORT annual cash & cash equivalents is now -5.82% below its all-time high of $135.55 million, reached on December 31, 2023.
Performance
CORT Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$89.82M-$37.85M(-29.64%)Summary
- As of today (May 20, 2025), CORT quarterly cash & cash equivalents is $89.82 million, with the most recent change of -$37.85 million (-29.64%) on March 31, 2025.
- Over the past year, CORT quarterly cash & cash equivalents has dropped by -$59.93 million (-40.02%).
- CORT quarterly cash & cash equivalents is now -70.05% below its all-time high of $299.94 million, reached on March 31, 2023.
Performance
CORT quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CORT Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.8% | -40.0% |
| 3 y3 years | +64.5% | +45.2% |
| 5 y5 years | +308.3% | +6.3% |
CORT Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.8% | +92.5% | -70.0% | +154.1% |
| 5 y | 5-year | -5.8% | +308.3% | -70.0% | +193.9% |
| alltime | all time | -5.8% | +3245.5% | -70.0% | +6261.1% |
CORT Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $89.82M(-29.6%) |
| Dec 2024 | $127.67M(-5.8%) | $127.67M(-7.0%) |
| Sep 2024 | - | $137.29M(+6.8%) |
| Jun 2024 | - | $128.59M(-14.1%) |
| Mar 2024 | - | $149.75M(+10.5%) |
| Dec 2023 | $135.55M(+104.4%) | $135.55M(+21.2%) |
| Sep 2023 | - | $111.80M(-35.1%) |
| Jun 2023 | - | $172.38M(-42.5%) |
| Mar 2023 | - | $299.94M(+352.2%) |
| Dec 2022 | $66.33M(-14.5%) | $66.33M(+32.0%) |
| Sep 2022 | - | $50.24M(+42.1%) |
| Jun 2022 | - | $35.35M(-42.9%) |
| Mar 2022 | - | $61.86M(-20.3%) |
| Dec 2021 | $77.62M(+1.9%) | $77.62M(-18.0%) |
| Sep 2021 | - | $94.69M(-0.8%) |
| Jun 2021 | - | $95.43M(+82.2%) |
| Mar 2021 | - | $52.38M(-31.2%) |
| Dec 2020 | $76.19M(+143.7%) | $76.19M(+149.3%) |
| Sep 2020 | - | $30.56M(-47.8%) |
| Jun 2020 | - | $58.52M(-30.7%) |
| Mar 2020 | - | $84.48M(+170.2%) |
| Dec 2019 | $31.27M(-24.9%) | $31.27M(-30.4%) |
| Sep 2019 | - | $44.95M(-22.7%) |
| Jun 2019 | - | $58.14M(+17.1%) |
| Mar 2019 | - | $49.65M(+19.3%) |
| Dec 2018 | $41.63M(+34.0%) | $41.63M(+22.8%) |
| Sep 2018 | - | $33.89M(+8.8%) |
| Jun 2018 | - | $31.16M(-5.9%) |
| Mar 2018 | - | $33.12M(+6.6%) |
| Dec 2017 | $31.06M(-39.7%) | $31.06M(+0.0%) |
| Sep 2017 | - | $31.06M(-7.6%) |
| Jun 2017 | - | $33.62M(-11.5%) |
| Mar 2017 | - | $37.98M(-26.3%) |
| Dec 2016 | $51.54M(+27.5%) | $51.54M(+7.7%) |
| Sep 2016 | - | $47.87M(+14.5%) |
| Jun 2016 | - | $41.79M(+2.6%) |
| Mar 2016 | - | $40.74M(+0.8%) |
| Dec 2015 | $40.44M(+66.8%) | $40.44M(+10.9%) |
| Sep 2015 | - | $36.45M(-1.6%) |
| Jun 2015 | - | $37.05M(-2.4%) |
| Mar 2015 | - | $37.95M(+56.5%) |
| Dec 2014 | $24.25M | $24.25M(-9.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2014 | - | $26.78M(-21.2%) |
| Jun 2014 | - | $33.97M(-22.1%) |
| Mar 2014 | - | $43.62M(-20.5%) |
| Dec 2013 | $54.88M(-41.0%) | $54.88M(-13.1%) |
| Sep 2013 | - | $63.17M(-12.5%) |
| Jun 2013 | - | $72.22M(-11.3%) |
| Mar 2013 | - | $81.46M(-12.4%) |
| Dec 2012 | $93.03M(+134.7%) | $93.03M(-8.5%) |
| Sep 2012 | - | $101.63M(+191.2%) |
| Jun 2012 | - | $34.90M(-18.1%) |
| Mar 2012 | - | $42.63M(+7.5%) |
| Dec 2011 | $39.63M(+61.3%) | $39.63M(-13.7%) |
| Sep 2011 | - | $45.91M(-12.1%) |
| Jun 2011 | - | $52.23M(-11.8%) |
| Mar 2011 | - | $59.20M(+140.9%) |
| Dec 2010 | $24.58M(+3.0%) | $24.58M(-30.5%) |
| Jun 2010 | - | $35.38M(+90.8%) |
| Mar 2010 | - | $18.55M(-22.3%) |
| Dec 2009 | $23.87M(+62.2%) | $23.87M(+122.7%) |
| Sep 2009 | - | $10.72M(-25.8%) |
| Jun 2009 | - | $14.45M(-24.7%) |
| Mar 2009 | - | $19.19M(+30.4%) |
| Dec 2008 | $14.72M(+28.7%) | $14.72M(-9.8%) |
| Sep 2008 | - | $16.32M(-37.5%) |
| Jun 2008 | - | $26.12M(-17.8%) |
| Mar 2008 | - | $31.79M(+178.1%) |
| Dec 2007 | $11.43M(+28.4%) | $11.43M(-38.4%) |
| Sep 2007 | - | $18.57M(+55.4%) |
| Jun 2007 | - | $11.95M(-19.0%) |
| Mar 2007 | - | $14.74M(+65.6%) |
| Dec 2006 | $8.91M(+133.4%) | $8.91M(+170.2%) |
| Sep 2006 | - | $3.30M(-13.7%) |
| Jun 2006 | - | $3.82M(+79.1%) |
| Mar 2006 | - | $2.13M(-44.1%) |
| Dec 2005 | $3.82M(-35.6%) | $3.82M(+170.3%) |
| Sep 2005 | - | $1.41M(-50.0%) |
| Jun 2005 | - | $2.83M(-19.3%) |
| Mar 2005 | - | $3.50M(-41.0%) |
| Dec 2004 | $5.93M | $5.93M(-73.1%) |
| Sep 2004 | - | $22.02M(-37.5%) |
| Jun 2004 | - | $35.24M(+291.8%) |
| Mar 2004 | - | $8.99M |
FAQ
- What is Corcept Therapeutics Incorporated annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual cash & cash equivalents year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly cash & cash equivalents year-on-year change?
What is Corcept Therapeutics Incorporated annual cash & cash equivalents?
The current annual cash & cash equivalents of CORT is $127.67M
What is the all time high annual cash & cash equivalents for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual cash & cash equivalents is $135.55M
What is Corcept Therapeutics Incorporated annual cash & cash equivalents year-on-year change?
Over the past year, CORT annual cash & cash equivalents has changed by -$7.89M (-5.82%)
What is Corcept Therapeutics Incorporated quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of CORT is $89.82M
What is the all time high quarterly cash & cash equivalents for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly cash & cash equivalents is $299.94M
What is Corcept Therapeutics Incorporated quarterly cash & cash equivalents year-on-year change?
Over the past year, CORT quarterly cash & cash equivalents has changed by -$59.93M (-40.02%)